MX157315A - Procedimiento para la depuracion de un factor o varios factores de coagulacion de sangre del grupo de factores ii,vii,ix y x - Google Patents

Procedimiento para la depuracion de un factor o varios factores de coagulacion de sangre del grupo de factores ii,vii,ix y x

Info

Publication number
MX157315A
MX157315A MX191056A MX19105682A MX157315A MX 157315 A MX157315 A MX 157315A MX 191056 A MX191056 A MX 191056A MX 19105682 A MX19105682 A MX 19105682A MX 157315 A MX157315 A MX 157315A
Authority
MX
Mexico
Prior art keywords
factors
vii
purification
factor
procedure
Prior art date
Application number
MX191056A
Other languages
English (en)
Spanish (es)
Inventor
Horst Schwinn
Norbert Heimburger
Gerhardt Kumpe
Heinz Hermann Drescher
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of MX157315A publication Critical patent/MX157315A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/647Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
MX191056A 1981-01-21 1982-01-20 Procedimiento para la depuracion de un factor o varios factores de coagulacion de sangre del grupo de factores ii,vii,ix y x MX157315A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813101752 DE3101752A1 (de) 1981-01-21 1981-01-21 "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"

Publications (1)

Publication Number Publication Date
MX157315A true MX157315A (es) 1988-11-15

Family

ID=6123007

Family Applications (1)

Application Number Title Priority Date Filing Date
MX191056A MX157315A (es) 1981-01-21 1982-01-20 Procedimiento para la depuracion de un factor o varios factores de coagulacion de sangre del grupo de factores ii,vii,ix y x

Country Status (10)

Country Link
US (1) US4411794A (enEXAMPLES)
EP (1) EP0056629B1 (enEXAMPLES)
JP (1) JPS57139017A (enEXAMPLES)
AT (1) ATE13304T1 (enEXAMPLES)
AU (1) AU546434B2 (enEXAMPLES)
CA (1) CA1186626A (enEXAMPLES)
DE (2) DE3101752A1 (enEXAMPLES)
ES (1) ES508756A0 (enEXAMPLES)
IL (1) IL64823A (enEXAMPLES)
MX (1) MX157315A (enEXAMPLES)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
US5614500A (en) * 1983-03-04 1997-03-25 The Scripps Research Institute Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
FR2561074B1 (fr) * 1984-03-15 1986-10-31 Lille I Universite Sciences Te Procede de decoloration de substances colorees par des composes tetrapyrroliques, et produits obtenus
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
DE3615558A1 (de) * 1986-05-09 1987-11-12 Behringwerke Ag Verfahren zur herstellung eines faktor v-konzentrats
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
JPH0653170B2 (ja) * 1986-07-07 1994-07-20 旭光学工業株式会社 β2ミクログロブリン吸着剤
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
DE3914869C1 (enEXAMPLES) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3933093A1 (de) * 1989-10-04 1991-04-11 Bayer Ag Verfahren zur herstellung von 2,4- bzw. 2,6-dihalogen-anilin
SG48282A1 (en) * 1991-03-01 1998-04-17 Centeon Llc Preparation of factor ix
DE4406515C1 (de) * 1994-02-28 1995-10-19 Immuno Ag Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine
US5714583A (en) * 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
WO2003099412A1 (en) 2002-05-24 2003-12-04 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
CA2683423C (en) * 2007-04-26 2020-10-27 Inspiration Biopharmaceuticals, Inc. Recombinant vitamin k dependent proteins with high sialic acid content and methods of preparing same
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
FR2946348B1 (fr) 2009-06-05 2011-08-05 Lab Francais Du Fractionnement Procede de preparation d'une composition de complexe prothrombique a haut degre de purete
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
ES2913934T3 (es) 2017-02-09 2022-06-06 Csl Behring Gmbh Un producto de sustitución del factor de coagulación de la sangre para su uso en el tratamiento o la profilaxis de las hemorragias

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen

Also Published As

Publication number Publication date
IL64823A (en) 1985-07-31
US4411794A (en) 1983-10-25
JPH0150208B2 (enEXAMPLES) 1989-10-27
AU7966182A (en) 1982-07-29
AU546434B2 (en) 1985-08-29
DE3101752A1 (de) 1982-08-26
ES8305376A1 (es) 1983-04-01
IL64823A0 (en) 1982-03-31
ES508756A0 (es) 1983-04-01
DE3263450D1 (en) 1985-06-20
EP0056629A1 (de) 1982-07-28
EP0056629B1 (de) 1985-05-15
JPS57139017A (en) 1982-08-27
ATE13304T1 (de) 1985-06-15
CA1186626A (en) 1985-05-07

Similar Documents

Publication Publication Date Title
MX157315A (es) Procedimiento para la depuracion de un factor o varios factores de coagulacion de sangre del grupo de factores ii,vii,ix y x
ATE384T1 (de) Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen.
GB1147615A (en) Improvements in or relating to the purification of liquids
DE3577038D1 (de) Verfahren zur selektiven adsorption von heparin.
GB2110932A (en) Method and composition for treating acne
EP0053338A3 (en) Process for the preparation of blood coagulation factors, and preparation containing factors ix and x
ES8307102A1 (es) Un metodo para la absorcion de sustancias uremicas en un rinon artificial.
ATE85764T1 (de) Verfahren zur behandlung von industriellen gasen, die schwefelverbindungen enthalten.
ES2020538B3 (es) Procedimiento para la separacion de vinilpirrolidona de los polimerizados de vinilpirrolidona.
AR244574A1 (es) Un adsorbente con base de alumina para la purificacion de olefinas y procedimiento para prepararlo.
DE3868980D1 (de) Zeolith a-granulat fuer sauerstoffanreicherung.
ATE53302T1 (de) Mittel zur behandlung von wunden.
ATE21531T1 (de) Verfahren zur regenerierung waessriger entfettungs- und reinigungsloesungen.
EP0209786A3 (en) Process for purifying human tumour necrosis factor
ES516373A0 (es) Procedimiento para reducir la acidez de fluidos funcionales de organofosfatos.
MA20244A1 (fr) Procede de traitement de dechets contenant du phosphore.
MA19794A1 (fr) Procede de traitement d'effluents d'hydrocarbures liquides uses chlores contenat du fer .
NO832331L (no) Fremgangsmaate for rensing av soetningsmiddelopploesninger
AU1239795A (en) Purified stable liquid prealbumin
FR2549041B1 (fr) Procede de purification de 4-fluorophenol
ES2086038T3 (es) Procedimiento para la determinacion de fibrina.
PT82300B (pt) Processo para determinacao imunologica de heparanosulfato-proteoglicano, processo para a preparacao ou para a purificacao de heparanosulfato-proteoglicano apropriado para o mesmo a partir de tecidos contendo membranas basais
ZA8349B (en) Method of reducing the calcium concentration of aqueous solutions
PT77748B (de) Bausatz zur herstellung von lichtrohrsystemen oder raumfachwer-ken
IT1233935B (it) Procedimento e apparecchio per la rimozione di ioni fosfato dal sangue